Search Results for "lipid biosynthetic process" - 131 interactions found in 81 entries.

Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
258
1058 SREBF1 increases_activity of lipid biosynthetic process in liver; when excess energy by carbohydrates is consumed
10585467 Diabetes mellitus, type II
Insulin resistance
276
1132 SREBF1c affects_activity of lipid biosynthetic process in liver
10535992 Diabetes mellitus, type II
Insulin resistance
282
1185 SREBF1c affects_activity of lipid biosynthetic process
10207099 Diabetes mellitus, type II
Insulin resistance
315
1250 decreased insulin sensitivity increases_activity of lipid biosynthetic process
10949029 Diabetes mellitus, type II
Insulin resistance
459
2037 STK11 affects_activity of lipid biosynthetic process
16308421 Diabetes mellitus, type II
Peutz-Jeghers syndrome
Insulin resistance
462
12367 PRKAA2 decreases_activity of lipid biosynthetic process
15855317 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
578
12839 NR1H-RXR complex affects_activity of lipid biosynthetic process via SREBF1c expression
11287605 Diabetes mellitus, type II
Insulin resistance
664
3566 ACS affects_activity of lipid biosynthetic process
10940327 Diabetes mellitus, type II
Diabetes mellitus, type I
Insulin resistance
Hypothyroidism
714
3960 increased liver free fatty acid level increases_activity of lipid biosynthetic process in liver
18927507 Diabetes mellitus, type II
Abetalipoproteinemia
Insulin resistance
Fatty liver disease, nonalcoholic
Cardiovascular disease
732
4109 Polyunsaturated fatty acid decreases_activity of lipid biosynthetic process in liver
16614395 Diabetes mellitus, type II
Insulin resistance
736
4237 LPIN1B increases_activity of lipid biosynthetic process
18023282 Diabetes mellitus, type II
Obesity
Lipodystrophy
Insulin resistance
Fatty liver disease, nonalcoholic
Majeed syndrome
787
4458 LPIN1 decreases_activity of lipid biosynthetic process if LPIN1 is overexpressed
16950137 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
824
4935 MLXIPL increases_activity of lipid biosynthetic process in liver; independent of SREBF1c
4997 SREBF affects_activity of lipid biosynthetic process if SREBF is overexpressed
5002 PPARG increases_activity of lipid biosynthetic process in white adipose tissue
19770177 Diabetes mellitus, type II
Obesity
Insulin resistance
889
5250 PPARGC1B affects_activity of lipid biosynthetic process in liver; after high-fructose diet, if PPARGC1B expression is knocked down
5297 PPARGC1B affects_activity of lipid biosynthetic process in liver; induced by fructose, if PPARGC1B expression is knocked down
19254570 Diabetes mellitus, type II
Insulin resistance
1,267
8636 FASN increases_activity of lipid biosynthetic process in white adipose tissue
18522830 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
1,519
10770 Polyunsaturated fatty acid, omega-3 affects_activity of lipid biosynthetic process in liver
19211925 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
1,656
12183 Insulin increases_activity of lipid biosynthetic process after chronic intracerebroventricular insulin treatment of control mice
18451994 Diabetes mellitus, type II
Insulin resistance
2,228
18857 Coffee polyphenol decreases_activity of lipid biosynthetic process via downregulation of SREBF1c
20943752 Diabetes mellitus, type II
Insulin resistance
2,266
19352 SPP1 affects_activity of lipid biosynthetic process in liver
21562757 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
2,653
25072 GCKR rs1260326 increases_activity of lipid biosynthetic process in liver
22038520 Diabetes mellitus, type II
Insulin resistance
2,696
25233 DUSP9 decreases_activity of lipid biosynthetic process
18296638 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
3,105
28499 LEP decreases_activity of lipid biosynthetic process
28508 Anandamide increases_activity of lipid biosynthetic process
18516053 Diabetes mellitus, type II
Insulin resistance
3,195
29342 Corticosterone NOT increases_activity of lipid biosynthetic process
20943959 Diabetes mellitus, type II
Insulin resistance
3,346
30746 Compound 2922 decreases_activity of lipid biosynthetic process in liver
18479468 Diabetes mellitus, type II
Obesity
Insulin resistance
3,376
31386 fat cell differentiation affects_activity of lipid biosynthetic process
31390 lipid biosynthetic process increases_activity of increased white fat cell size
22022575 Diabetes mellitus, type II
Insulin resistance
Cushing syndrome
3,377
31380 fat cell differentiation increases_activity of lipid biosynthetic process
31410 Glucocorticoid decreases_activity of lipid biosynthetic process
31412 Insulin increases_activity of lipid biosynthetic process
31413 Dexamethasone affects_activity of lipid biosynthetic process via insulin
31414 Cortisol decreases_activity of lipid biosynthetic process
31415 Cortisone decreases_activity of lipid biosynthetic process
31416 HSD11B1 affects_activity of lipid biosynthetic process via cortisone
22022575 Diabetes mellitus, type II
Insulin resistance
3,622
34284 Triiodothyronine increases_activity of lipid biosynthetic process in liver; via increased ME activity
34321 SREBF1c affects_activity of lipid biosynthetic process in adipose tissue
21941681 Diabetes mellitus, type II
Insulin resistance
Hypothyroidism
Hyperthyroidism
3,632
34489 NR1H4 affects_activity of lipid biosynthetic process
34516 Bile acid-binding resin increases_activity of lipid biosynthetic process via NR1H4 and LXR
21431855 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
3,659
34873 lipid biosynthetic process affects_activity of triglyceride-fatty acid cycle
34875 lipid biosynthetic process decreases_quantity of Glycerol 3-phosphate
34907 lipid biosynthetic process increases_activity of hyperlipidemia
34909 Estrogen decreases_activity of lipid biosynthetic process
22108437 Diabetes mellitus, type II
Insulin resistance
3,890
39309 SREBF1c increases_activity of lipid biosynthetic process in liver
22941588 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
Metabolic syndrome
-->